izvor podataka: crosbi
!
The Utility of Thyroid Transcription Factor 1 (TTF-1), Napsin A, Excision Repair Cross- Complementing 1 (ERCC1), Anaplastic Lymphoma Kinase (ALK) and the Epidermal Growth Factor Receptor (EGFR) Expression in Small Biopsy in Prognosis of Patients with Lung Adenocarcinoma - A Retrograde Single-Center Study from Croatia (CROSBI ID 272207)
Prilog u časopisu | izvorni znanstveni rad | međunarodna recenzija
Piljić Burazer, Marina ; Mladinov, Suzana ; Ćapkun, Vesna ; Kuret, Sendi ; Glavina Durdov, Merica
The Utility of Thyroid Transcription Factor 1 (TTF-1), Napsin A, Excision Repair Cross- Complementing 1 (ERCC1), Anaplastic Lymphoma Kinase (ALK) and the Epidermal Growth Factor Receptor (EGFR) Expression in Small Biopsy in Prognosis of Patients with Lun // Medical science monitor, 23 (2017), 489-497
Podaci o odgovornosti
Piljić Burazer, Marina ; Mladinov, Suzana ; Ćapkun, Vesna ; Kuret, Sendi ; Glavina Durdov, Merica
engleski
The Utility of Thyroid Transcription Factor 1 (TTF-1), Napsin A, Excision Repair Cross- Complementing 1 (ERCC1), Anaplastic Lymphoma Kinase (ALK) and the Epidermal Growth Factor Receptor (EGFR) Expression in Small Biopsy in Prognosis of Patients with Lung Adenocarcinoma - A Retrograde Single-Center Study from Croatia
/
Carcinoma, Non-small cell lung, Diagnosis, Immunohistochemistry, Pathology, Prognosis, Real-time polymerase chain reaction
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
Podaci o izdanju
Povezanost rada
Povezane osobe
Povezane ustanove
